The landscape of rare diseases is complex and multifaceted, presenting unique challenges and opportunities for the pharmaceutical industry. In this webinar we will provide a comprehensive analysis of the rare disease sector, exploring regulatory guidelines, regional prevalence, market access, and the key players driving innovation in this crucial area of healthcare.
We conducted a comprehensive analysis of drug candidates in clinical development and those launched for the top rare diseases. The webinar and subsequent report delve into:
- Market sizing for these drugs
- Specific challenges faced by the pharmaceutical sector
- The number of rare diseases targeted by pharma companies over the past five years
- Top-selling orphan drugs, and key players in the market
Speaker
Samreen Shaikh
Lead Pharma Solutions
Springer Nature
Samreen Shaikh is the Lead Pharma Solutions at Springer Nature, Pune, with over 15 years of experience in the field, including 6 years in Pharma Solutions at Springer Nature. She joined Springer Nature in 2018 and has been instrumental in handling new initiatives and is a subject matter expert in the AdisInsight team. Additionally, Ms. Shaikh has an impressive academic background, with 9 years of experience as an Assistant Professor at Pune University, India. She holds an M.S. (Pharm) degree specializing in Medicinal Chemistry from National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.
Interested in September 18 session at 12 pm EDT | 6 pm CET?
Register Here
Register for free webinar
September 19, 2024 | 9 am CET | 4 pm JST